Cargando…

Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8‐ to 10‐Year Period

BACKGROUND: Cavalier King Charles Spaniels (CKCS) are predisposed to myxomatous mitral valve disease (MMVD). Studies have indicated a strong genetic background. OBJECTIVE: The aim of this study was to evaluate the effect of a breeding scheme involving auscultation and echocardiography. ANIMALS: In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birkegård, A.C., Reimann, M.J., Martinussen, T., Häggström, J., Pedersen, H.D., Olsen, L.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913653/ https://www.ncbi.nlm.nih.gov/pubmed/26578464 http://dx.doi.org/10.1111/jvim.13663

Ejemplares similares

Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels
por: Reimann, M.J., et al.
Publicado: (2017)

Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease
por: Reimann, Maria J., et al.
Publicado: (2021)

Myoclonus in older Cavalier King Charles Spaniels
por: Rotter, Carina, et al.
Publicado: (2022)

Comparison of the mitral valve morphologies of Cavalier King Charles Spaniels and dogs of other breeds using 3D transthoracic echocardiography
por: Menciotti, Giulio, et al.
Publicado: (2018)

Morphometric analysis of spinal cord termination in Cavalier King Charles Spaniels
por: Sparks, Courtney R., et al.
Publicado: (2019)

Degenerative Valvular Disease in the Cavalier King Charles Spaniel: Results of the UK Breed Scheme 1991–2010
por: Swift, S., et al.
Publicado: (2017)

No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan‐induced inhibition of platelet aggregation response
por: Reimann, Maria J., et al.
Publicado: (2023)

Investigation of sensory thresholds in Cavalier King Charles Spaniels with and without Chiari‐like malformations and syringomyelia
por: Sparks, Courtney R., et al.
Publicado: (2018)

Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
por: Christiansen, Liselotte B., et al.
Publicado: (2020)

Behavioral and clinical signs of Chiari‐like malformation‐associated pain and syringomyelia in Cavalier King Charles spaniels
por: Rusbridge, Clare, et al.
Publicado: (2019)

Association between filum terminale internum length and pain in Cavalier King Charles spaniels with and without syringomyelia
por: Sparks, Courtney R., et al.
Publicado: (2021)

A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels
por: Bionda, Arianna, et al.
Publicado: (2020)

Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel
por: Markby, G. R., et al.
Publicado: (2020)

Longitudinal Study of the Relationship among Craniocervical Morphology, Clinical Progression, and Syringomyelia in a Cohort of Cavalier King Charles Spaniels
por: Cerda‐Gonzalez, S., et al.
Publicado: (2016)

Facial changes related to brachycephaly in Cavalier King Charles Spaniels with Chiari‐like malformation associated pain and secondary syringomyelia
por: Knowler, Susan P., et al.
Publicado: (2019)

Allogenic blood patch pleurodesis for management of pneumothorax in a Cavalier King Charles Spaniel puppy with multiple pulmonary blebs and bullae
por: Moloney, Conor, et al.
Publicado: (2022)

Questionnaire‐based Analysis of Owner‐reported Scratching and Pain Signs in Cavalier King Charles Spaniels Screened for Chiari‐like Malformation and Syringomyelia
por: Sparks, C.R., et al.
Publicado: (2017)

Echocardiographic Evaluation of the Mitral Valve in Cavalier King Charles Spaniels
por: Bagardi, Mara, et al.
Publicado: (2020)

Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels
por: Mead, Sophie E., et al.
Publicado: (2022)

Depleted Myocardial Coenzyme Q10 in Cavalier King Charles Spaniels with Congestive Heart Failure Due to Myxomatous Mitral Valve Disease
por: Christiansen, Liselotte B., et al.
Publicado: (2021)

Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration
por: Reimann, M.J., et al.
Publicado: (2017)

Evaluation of the Swedish breeding program for cavalier King Charles spaniels
por: Lundin, Tobias, et al.
Publicado: (2010)

Using machine learning to understand neuromorphological change and image‐based biomarker identification in Cavalier King Charles Spaniels with Chiari‐like malformation‐associated pain and syringomyelia
por: Spiteri, Michaela, et al.
Publicado: (2019)

The genetic consequences of dog breed formation—Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels
por: Axelsson, Erik, et al.
Publicado: (2021)

Correction: The genetic consequences of dog breed formation—Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels
por: Axelsson, Erik, et al.
Publicado: (2022)

Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease
por: Bagardi, Mara, et al.
Publicado: (2022)

Pilot study of head conformation changes over time in the Cavalier King Charles spaniel breed
por: Knowler, Susan Penelope, et al.
Publicado: (2019)

Volume reduction of the jugular foramina in Cavalier King Charles Spaniels with syringomyelia
por: Schmidt, Martin Jürgen, et al.
Publicado: (2012)

Medical infrared thermal imaging of syringomyelia in the Cavalier King Charles Spaniel
por: Larkin, M., et al.
Publicado: (2020)

Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels
por: Prieto Ramos, Jorge, et al.
Publicado: (2021)

Assessing the relative importance of health and conformation traits in the cavalier king Charles spaniel
por: Wijnrocx, Katrien, et al.
Publicado: (2018)

Erratum for Morphometric analysis of spinal cord termination in Cavalier King Charles Spaniels
Publicado: (2019)

Mechanical quantitative sensory testing in cavalier King Charles spaniels with and without syringomyelia
por: Hechler, Ashley C., et al.
Publicado: (2020)

Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
por: Tidholm, A., et al.
Publicado: (2015)

Syringomyelia: determining risk and protective factors in the conformation of the Cavalier King Charles Spaniel dog
por: Mitchell, Thomas J, et al.
Publicado: (2014)

Corpus Callosotomy in 3 Cavalier King Charles Spaniel Dogs with Drug-Resistant Epilepsy
por: Asada, Rikako, et al.
Publicado: (2021)

Real‐Time 3‐Dimensional Echocardiographic Assessment of Effective Regurgitant Orifice Area in Dogs With Myxomatous Mitral Valve Disease
por: Tidholm, A., et al.
Publicado: (2017)

Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease
por: Kim, H.‐S., et al.
Publicado: (2016)

Influence of Morphometry on Echocardiographic Measurements in Cavalier King Charles Spaniels: An Inverse Probability Weighting Analysis
por: Bagardi, Mara, et al.
Publicado: (2021)

Ventriculomegaly in Cavalier King Charles Spaniels with Chiari-like malformation: relationship with clinical and imaging findings
por: TIRRITO, Federica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6raqq4a27rbl5tfpbvf30ck33j